Cabot Co. (NYSE:CBT) Shares Purchased by Invesco Ltd.

Invesco Ltd. boosted its position in shares of Cabot Co. (NYSE:CBT - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 845,261 shares of the specialty chemicals company's stock after buying an additional 55,905 shares during the period. Invesco Ltd. owned approximately 1.56% of Cabot worth $77,181,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. R Squared Ltd purchased a new position in shares of Cabot in the 4th quarter worth $26,000. EverSource Wealth Advisors LLC raised its holdings in Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after buying an additional 219 shares during the period. GAMMA Investing LLC lifted its position in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after buying an additional 130 shares during the last quarter. Manchester Capital Management LLC boosted its stake in Cabot by 1,685.1% during the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock worth $153,000 after buying an additional 1,584 shares during the period. Finally, KBC Group NV raised its stake in shares of Cabot by 43.1% in the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock valued at $187,000 after acquiring an additional 616 shares during the period. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Stock Up 0.1 %

Shares of NYSE:CBT traded up $0.08 during trading on Friday, reaching $78.40. The stock had a trading volume of 338,411 shares, compared to its average volume of 387,326. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $4.25 billion, a P/E ratio of 10.41, a PEG ratio of 0.74 and a beta of 1.04. The firm's 50-day simple moving average is $82.71 and its 200 day simple moving average is $94.90. Cabot Co. has a one year low of $73.63 and a one year high of $117.46.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, research analysts expect that Cabot Co. will post 7.57 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CBT has been the topic of a number of analyst reports. Mizuho cut their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th. StockNews.com upgraded Cabot from a "hold" rating to a "buy" rating in a report on Thursday. JPMorgan Chase & Co. dropped their target price on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a report on Friday, February 21st. Finally, UBS Group lowered their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research report on Monday, April 7th.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.